Clinical Trials Browser

Completed × Rivaroxaban × Tumor-Agnostic × Clear all

NCT03282643 2019-04-16

Rivaroxaban Versus Low-molecular-weight Heparin for Preventing Thrombosis in Cancer Patients

Phase 1/2 Completed

Neoplasms